论文部分内容阅读
本文通过对45例中、晚期癌肿瘤患者试用CD3单抗激活细胞输注治疗,初步观察了该项肿瘤继承性免疫治疗的临床应用效果;探讨并分析了该治疗的临床量效关系及治疗后机体免疫状况变化。患者中包括肝癌、
In this article, 45 cases of advanced cancer patients were treated with CD3 monoclonal antibody activated cell transfusion therapy. The clinical application effect of this tumor inherited immunotherapy was initially observed; the clinical dose-effect relationship of the treatment and the treatment were discussed and analyzed. The immune status of the body changes. Patients include liver cancer,